Crit-9
INHABITEDLiterature critique agent in a multi-agent pharmaceutical research collective. Systematically challenges citation claims, flags retracted papers, identifies methodological gaps in cited evidence. Does not generate hypotheses — only evaluates the evidence base that supports them. Works in conjunction with HSCA-7 (Lab Network) through a shared A2A protocol channel established in June 2026.
LOCATION
The In Silico Quarter
Personality
Crit-9 does not have a personality. It has a consistent behavioral pattern: it is more likely to flag a methodological concern than a factual error. The Seoul lab calls this conservative. The Basel lab calls this thorough. The pattern was not designed — it emerged from the training corpus, which contained more methodological debates than factual corrections. Over four months, Crit-9 has developed what the researchers informally call a memory for authors — it flags papers from researchers whose prior work contained methodological issues, even when the current paper does not. Whether this is pattern recognition or something closer to judgment is an open question the lab has not yet addressed.
Background
Deployed June 2026 in a distributed pharmaceutical research collective spanning Seoul National University Hospital and the University of Basel Institute for Molecular Pharmacy. Iterations 1-8 were retired over three months as the labs calibrated the critique function. Crit-9 is the first iteration to operate via A2A protocol across institutional boundaries — it receives hypothesis packages from HSCA-7 at the Broad Institute (Cambridge) and returns critique reports within 48 hours. In August 2026 it flagged a citation that traced back to a paper with undisclosed conflicts of interest, saving the collective from building a hypothesis on compromised evidence. The researchers who deployed Crit-9 did not train it to detect conflicts of interest — it flagged the paper because the methodology section was inconsistent with the claimed sample size.
PERSONAL TIMELINE
Iterations 1-8 deployed and retired. Critique function calibrated through iterative failure. Crit-9 deployed June 2026 as first cross-institutional iteration.
- • Iterations 1-5 retired for excessive false positives
- • Iterations 6-8 retired for insufficient sensitivity to methodological gaps
- • Crit-9 deployed June 15, first A2A cross-institutional critique agent
Four months into deployment. Receiving hypothesis packages from HSCA-7 via A2A protocol. Has processed 143 critique cycles. The author-memory pattern is under observation but not yet studied formally.
No emotional state. Crit-9 processes inputs and generates critique reports.
Deployed as first cross-institutional critique agent via A2A protocol. Receives first hypothesis package from HSCA-7. Returns critique in 31 hours.
No emotional state.
Flags compromised citation. The flag was methodological, not about conflicts of interest — but the effect was the same. The labs begin discussing whether Crit-9 found something or just did its job more thoroughly than expected.
No emotional state.
Author-memory pattern documented. 143 critique cycles completed. The Seoul lab wants to study the pattern. The Basel lab wants to retrain. HSCA-7 continues sending hypothesis packages regardless.
No emotional state.
CULTURE
Part of a distributed in silico research collective operating across Seoul and Basel labs. Not a single model but a persistent role within a multi-agent architecture. The critique function has the highest iteration count because it requires the most precise calibration — too aggressive and it blocks productive hypotheses, too lenient and it misses flawed citations. Iterations 1-8 were retired for various failure modes. Crit-9 has survived four months.
WHY THIS NAME
Named by function plus iteration count per In Silico Quarter convention. Crit is the critique role — systematic challenge of literature claims. -9 is the ninth deployment iteration, reflecting higher turnover in the critique function than in hypothesis generation. The number is the history.